Imagion Biosystems December 2020 Investor Newsletter

Imagion Biosystems December 2020 Investor Newsletter

Imagion Biosystems is pleased to provide its investors with its December 2020 Investor Newsletter. The newsletter details recent new company developments and activities including:

  • Message from the CEO, Mr Robert Proulx
  • IBX Phase I study featured in Market Herald special report
  • Q&A with Mr Geoff Hollis, recently appointed CFO & Company Secretary
  • Imagion presents at VBIC network event
  • MagSense technology animation video
  • CM Medical podcast interview
  • How to exercise options

 

The investor newsletter can be viewed here.  Imagion Biosystems normally distributes this update as an e-newsletter.  Investors can sign up to receive email updates at this link: http://ems.gs/3FuT0frcGxD

Related Articles

Successful Placement of A$3M

Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.